4-amino-9-ethyl-9-hydroxy-(9S)-1,2,9,10,13,15-hexahydro-12H-pyrano[4,3,2-de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione

ID: ALA441058

Chembl Id: CHEMBL441058

PubChem CID: 44314228

Max Phase: Preclinical

Molecular Formula: C22H19N3O5

Molecular Weight: 405.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccc(N)c3c1c2CCO3

Standard InChI:  InChI=1S/C22H19N3O5/c1-2-22(28)13-7-16-18-11(8-25(16)20(26)12(13)9-30-21(22)27)10-5-6-29-19-14(23)3-4-15(24-18)17(10)19/h3-4,7,28H,2,5-6,8-9,23H2,1H3/t22-/m0/s1

Standard InChI Key:  WDIISTCWBKBIBM-QFIPXVFZSA-N

Associated Targets(Human)

HOC-21 cell line (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
QG-56 (221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 405.41Molecular Weight (Monoisotopic): 405.1325AlogP: 1.60#Rotatable Bonds: 1
Polar Surface Area: 116.67Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.70CX Basic pKa: 4.67CX LogP: 0.27CX LogD: 0.27
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.36Np Likeness Score: 0.94

References

1. Sugimori M, Ejima A, Ohsuki S, Uoto K, Mitsui I, Kawato Y, Hirota Y, Sato K, Terasawa H..  (1998)  Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.,  41  (13): [PMID:9632364] [10.1021/jm970765q]

Source